- Home
- AXDX vs ASBP Comparison
AXDX vs ASBP Comparison
Compare AXDX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- ASBP
- Stock Information
- Founded
- AXDX 1982
- ASBP 2021
- Country
- AXDX United States
- ASBP United States
- Employees
- AXDX N/A
- ASBP N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- AXDX Industrials
- ASBP Health Care
- Exchange
- AXDX Nasdaq
- ASBP Nasdaq
- Market Cap
- AXDX 13.7M
- ASBP 26.6M
- IPO Year
- AXDX 1996
- ASBP N/A
- Fundamental
- Price
- AXDX $0.14
- ASBP $0.34
- Analyst Decision
- AXDX
- ASBP
- Analyst Count
- AXDX 0
- ASBP 0
- Target Price
- AXDX N/A
- ASBP N/A
- AVG Volume (30 Days)
- AXDX 425.6K
- ASBP 231.9K
- Earning Date
- AXDX 05-16-2025
- ASBP 05-24-2025
- Dividend Yield
- AXDX N/A
- ASBP N/A
- EPS Growth
- AXDX N/A
- ASBP N/A
- EPS
- AXDX N/A
- ASBP N/A
- Revenue
- AXDX $11,698,000.00
- ASBP N/A
- Revenue This Year
- AXDX $7.25
- ASBP N/A
- Revenue Next Year
- AXDX N/A
- ASBP N/A
- P/E Ratio
- AXDX N/A
- ASBP N/A
- Revenue Growth
- AXDX N/A
- ASBP N/A
- 52 Week Low
- AXDX $0.12
- ASBP $0.32
- 52 Week High
- AXDX $2.09
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- AXDX 14.62
- ASBP N/A
- Support Level
- AXDX $0.50
- ASBP N/A
- Resistance Level
- AXDX $0.56
- ASBP N/A
- Average True Range (ATR)
- AXDX 0.05
- ASBP 0.00
- MACD
- AXDX -0.01
- ASBP 0.00
- Stochastic Oscillator
- AXDX 4.44
- ASBP 0.00
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.